Last update 01 Nov 2024

Clonidine/Oxybutynin

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
+ [2]
Target
ADRA2 x M1 receptor x M2 receptor x M3 receptor
Mechanism
ADRA2 agonists(Adrenergic receptors alpha-2 agonists), M1 receptor antagonists(Muscarinic acetylcholine receptor M1 antagonists), M2 receptor antagonists(Muscarinic acetylcholine receptor M2 antagonists)
+ [1]
Therapeutic Areas
Mouth and Tooth Diseases
Active Indication
Sialorrhea
Inactive Indication-
Originator Organization
Summit Pharmaceuticals International Corp.Summit Pharmaceuticals International Corp.
Active Organization
Orient Pharma Co., Ltd.Orient Pharma Co., Ltd.Orient Europharma Co. Ltd.Orient Europharma Co. Ltd.Summit Pharmaceuticals International Corp.Summit Pharmaceuticals International Corp.
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
AU (04 Feb 2011),
Sialorrhea
Regulation-
Login to view timeline

Structure

Molecular FormulaC22H31NO3
InChIKeyXIQVNETUBQGFHX-UHFFFAOYSA-N
CAS Registry5633-20-5
View All Structures (2)

Related

100 Clinical Results associated with Clonidine/Oxybutynin
Login to view more data
100 Translational Medicine associated with Clonidine/Oxybutynin
Login to view more data
100 Patents (Medical) associated with Clonidine/Oxybutynin
Login to view more data
100 Deals associated with Clonidine/Oxybutynin
Login to view more data

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Sialorrhea
AU
Orient Pharma Co., Ltd.Orient Pharma Co., Ltd.
04 Feb 2011
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
SialorrheaPhase 1
CA
Orient Pharma Co., Ltd.Orient Pharma Co., Ltd.
-
SialorrheaPhase 1
NZ
Orient Pharma Co., Ltd.Orient Pharma Co., Ltd.
-
SialorrheaPhase 1
IN
Orient Pharma Co., Ltd.Orient Pharma Co., Ltd.
-
SialorrheaPhase 1
JP
Orient Pharma Co., Ltd.Orient Pharma Co., Ltd.
-
SialorrheaPhase 1
US
Orient Pharma Co., Ltd.Orient Pharma Co., Ltd.
-
SialorrheaPreclinical
NZ
Orient Pharma Co., Ltd.Orient Pharma Co., Ltd.
-
SialorrheaPreclinical
US
Orient Pharma Co., Ltd.Orient Pharma Co., Ltd.
-
SialorrheaPreclinical
CA
Orient Pharma Co., Ltd.Orient Pharma Co., Ltd.
-
SialorrheaPreclinical
JP
Orient Pharma Co., Ltd.Orient Pharma Co., Ltd.
-
SialorrheaPreclinical
IN
Orient Pharma Co., Ltd.Orient Pharma Co., Ltd.
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free